Broadcom
AVGO
Taiwan Semiconductor
TSM
Tesla
TSLA
ASML Holding
ASML
Qualcomm
QCOM
US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 2.050
- +0.140+7.33%
Close Dec 13 16:00 ET
- 2.070
- +0.020+0.98%
Post 19:58 ET
427.73MMarket Cap-2.89P/E (TTM)
2.175High1.930Low7.80MVolume1.990Open1.910Pre Close16.08MTurnover3.82%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High10.90P/B418.28MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM12.83%Amplitude0.291Historical Low2.062Avg Price1Lot Size
About Sangamo Therapeutics Company
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Company Profile
SymbolSGMO
Company NameSangamo Therapeutics
Listing DateApr 6, 2000
Issue Price15.00
Founded1995
CEODr. Alexander Donald Macrae, M.B.,PhD
MarketNASDAQ
Employees405
Fiscal Year Ends12-31
Address501 Canal Boulevard
CityRichmond
ProvinceCalifornia
CountryUnited States of America
Zip Code94084
Phone1-510-970-6000
Websitehttp://www.sangamo.com
Company Executives
- Name
- Position
- Salary
- Dr. Alexander Donald Macrae, M.B.,PhD
- Director, President and Chief Executive Officer
- 2.39M
- Nathalie Dubois-Stringfellow, PhD
- Senior Vice President and Chief Development Officer
- 1.03M
- Prathyusha Duraibabu
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.06M
- Scott B. Willoughby
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Amy Pooler, PhD
- Vice President and Head of Research
- --
- Margaret A. Horn, J.D.
- Independent Director
- 71.25K
- Dr. Kenneth J. Hillan, Ch.B.,M.B.
- Independent Director
- 71.16K
- Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 76.78K
- James R. Meyers
- Independent Director
- 78.66K
- Dr. John H. Markels, PhD
- Independent Director
- 76.78K
- Courtney Beers
- Independent Director
- 73.24K
- Robert F. Carey
- Independent Director
- 80.53K
- H. Stewart Parker
- Chairwoman of the Board
- 99.28K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
